How do different organ microbiomes influence neuropsychiatric disorders?
Can't see this email? View it online
   
  Cervical Cancer  
  The latest cervical cancer news from News Medical  
 Short course of induction chemotherapy can reduce cervical cancer relapse and death by 35%Short course of induction chemotherapy can reduce cervical cancer relapse and death by 35%
 
The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre, assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally advanced cervical cancer.
 
 
 How do different organ microbiomes influence neuropsychiatric disorders?How do different organ microbiomes influence neuropsychiatric disorders?
 
Scientists review existing literature to understand how the microbiome influences neuropsychiatric disorders.
 
   New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%
 
A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.
 
   Lactate-producing intratumoral bacteria drive resistance to radiation therapyLactate-producing intratumoral bacteria drive resistance to radiation therapy
 
Researchers at The University of Texas MD Anderson Cancer Center have discovered that lactate-producing intratumoral bacteria drives resistance to radiation therapy, suggesting that lactic acid-producing bacteria present in various cancers may serve as novel therapeutic targets.
 
   Lactobacillus iners in tumors: Driving chemoradiation resistance via lactate-induced metabolic rewiringLactobacillus iners in tumors: Driving chemoradiation resistance via lactate-induced metabolic rewiring
 
Investigating tumor and gut microbiome traits that impact chemoradiation therapy in patients with cervical cancer.
 
 Cervical cancer rates increasing in Appalachian Kentucky
 
Cervical cancer rates increasing in Appalachian KentuckyWhile the overall incidence and death rates from cervical cancer have dropped in the U.S., the opposite has been occurring in Appalachian Kentucky – a steady increase. The death rate from cervical cancer in Appalachian Kentucky is now twice that of the national rate.
 
 
 Women with disabilities have lower cervical cancer screening rates, study finds
 
Women with disabilities have lower cervical cancer screening rates, study findsAround 11,500 new cases of cervical cancer are diagnosed each year in the United States, according to the Centers for Disease Control (CDC). The CDC tracks cervical cancer rates by age, race, and ethnicity, but not by disability type.